Can a new drug stop smoldering myeloma before it becomes cancer?

NCT ID NCT05955508

First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 22 times

Summary

This study tests an investigational drug called linvoseltamab in 40 people with high-risk smoldering multiple myeloma, a condition that often leads to multiple myeloma. The goal is to see if the drug can safely eliminate abnormal plasma cells and prevent the disease from progressing. The study has two parts: first checking safety in a small group, then testing effectiveness in more participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMOLDERING MULTIPLE MYELOMA (SMM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinica Universidad de Navarra - Madrid

    Madrid, 28027, Spain

  • Clinica Universidad de Navarra - Pamplona

    Pamplona, Navarre, 31008, Spain

  • Hospital Clinic de Barcelona

    Barcelona, 08036, Spain

  • Hospital Clinico Universitario Santiago de Compostela

    Santiago de Compostela, A Coruna, 15706, Spain

  • Hospital Clinico Universitario Virgen De La Arrixaca

    El Palmar, Murcia, 30120, Spain

  • Hospital Clinico Universitario de Salamanca

    Salamanca, 37007, Spain

  • Hospital General Universitario Gregorio Maranon (HGUGM) - Instituto de Investigacion Sanitaria Gregorio Maranon

    Madrid, 28009, Spain

  • Hospital Germans Trias i Pujol

    Badalona, Barcelona, 08916, Spain

  • Hospital Universitari Son Llatzer

    Palma Mallorca, Balearic Islands, 07198, Spain

  • Hospital Universitario Marques de Valdecilla

    Santander, Cantabria, 39008, Spain

  • Hospital Universitario Quiron Salud Madrid

    Pozuelo de Alarcón, Madrid, 28223, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, Andalusia, 18014, Spain

  • Institut Catala d'Oncologia

    Barcelona, 08908, Spain

  • La Fe University Hospital

    Valencia, 46026, Spain

  • University Hospital Doctor Peset

    Valencia, 46017, Spain

  • University Hospital of Cabuenes

    Gijón, Principality of Asturias, 33203, Spain

Conditions

Explore the condition pages connected to this study.